Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali), 160062 Punjab, India.
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali), 160062 Punjab, India.
Mitochondrion. 2023 Mar;69:95-103. doi: 10.1016/j.mito.2023.02.003. Epub 2023 Feb 8.
Mitochondrial dysfunction is closely linked with the pathophysiology of several neurodegenerative disorders including Parkinson's disease (PD). Despite several therapeutic advancements related to symptomatic modification of PD pathology, strategies targeting mitochondrial dysfunctions remain largely elusive. Recently, transient receptor potential (TRP) channels have been shown to play a pivotal role in the control of mitochondrial and neuronal functioning in PD. In this study, the effect of 2-aminoethoxydiphenyl borate (2-APB), TRP channel blocker was investigated in the context of mitochondrial dysfunctions in 1-methyl-4-phenylpyridinium (MPP)-treated SH-SY5Y cells and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-administered Sprague Dawley rats. MPP-treated SH-SY5Y cells exhibited reductions in cell viability, generation of reactive oxygen species (ROS) and loss of mitochondrial membrane potential. Co-treatment with 2-APB led to an increase in cell viability, reduction in intracellular and mitochondrial ROS and improvement in mitochondrial membrane potential compared to MPP-treated SH-SY5Y cells. In addition, intranigral administration of MPTP led to a significant reduction in motor function in the rats. Fourteen days of 2-APB (3 and 10 mg/kg, i.p.) treatment improved behavioural parameters. MPTP-induced decrease in complex I activity and mitochondrial potential were also blocked by 2-APB in the mitochondria isolated from the brain regions i.e. midbrain and striatum. MPTP-induced decrease in tyrosine hydroxylase levels were also restored by 2-APB. Moreover, MPTP-induced reduction in proteins involved in mitochondrial biogenesis, viz. peroxisome proliferator-activated-receptor-gamma coactivator and mitochondrial transcription factor-A were increased after 2-APB treatment in vivo. In summary, 2-APB has a promising neuroprotective role in the MPP/MPTP models of PD via targeting mitochondrial dysfunctions and biogenesis.
线粒体功能障碍与包括帕金森病 (PD) 在内的几种神经退行性疾病的病理生理学密切相关。尽管在 PD 病理的症状修饰方面取得了一些治疗进展,但针对线粒体功能障碍的策略仍在很大程度上难以捉摸。最近,瞬态受体电位 (TRP) 通道已被证明在 PD 中线粒体和神经元功能的控制中发挥关键作用。在这项研究中,研究了 TRP 通道阻滞剂 2-氨基乙氧基二苯硼酸盐 (2-APB) 在 1-甲基-4-苯基吡啶鎓 (MPP) 处理的 SH-SY5Y 细胞和 1-甲基-4-苯基-1,2,3,6-四氢吡啶 (MPTP) 给药的 Sprague Dawley 大鼠中线粒体功能障碍中的作用。MPP 处理的 SH-SY5Y 细胞表现出细胞活力降低、活性氧 (ROS) 产生减少和线粒体膜电位丧失。与 MPP 处理的 SH-SY5Y 细胞相比,2-APB 共处理导致细胞活力增加、细胞内和线粒体 ROS 减少以及线粒体膜电位改善。此外,MPTP 侧脑室给药导致大鼠运动功能显著降低。2-APB(3 和 10mg/kg,ip)治疗 14 天可改善行为参数。2-APB 还可阻断 MPTP 诱导的脑区(中脑和纹状体)线粒体中复合物 I 活性和线粒体电位的降低。2-APB 还可恢复 MPTP 诱导的酪氨酸羟化酶水平降低。此外,2-APB 处理后,MPTP 诱导的与线粒体生物发生相关的蛋白质(过氧化物酶体增殖物激活受体-γ共激活因子和线粒体转录因子-A)增加。总之,2-APB 通过靶向线粒体功能障碍和生物发生在 MPP/MPTP 帕金森病模型中具有有前途的神经保护作用。